Xenetic Biosciences
XBIO • NASDAQ
Xenetic Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James F. Parslow, with a market cap of $7.2M.
Market Cap$7.2M
Employees4.0
CEOJames F. Parslow
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Xenetic Biosciences FAQ
Common questions about Xenetic Biosciences
Xenetic Biosciences is scheduled to report earnings for Q1 2026 on May 12, 2026.
Xenetic Biosciences has approximately 4 employees.